Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Testosterone-cypionate | hsa00040 | Pentose and glucuronate interconversions | 3.53E-02 | 1 | O60701 | UGDH | More | | Testosterone-cypionate | hsa00052 | Galactose metabolism | 2.91E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Testosterone-cypionate | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Testosterone-cypionate | hsa00100 | Steroid biosynthesis | 4.70E-02 | 1 | P35610 | SOAT1 | More | | Testosterone-cypionate | hsa00190 | Oxidative phosphorylation | 2.21E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Testosterone-cypionate | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Testosterone-cypionate | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Testosterone-cypionate | hsa00500 | Starch and sucrose metabolism | 1.98E-03 | 4 | O43451, P46976, P35557, P06737 | MGAM, GYG1, GCK, PYGL | More | | Testosterone-cypionate | hsa00512 | Mucin type O-glycan biosynthesis | 1.31E-03 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Testosterone-cypionate | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 4.70E-02 | 1 | P35557 | GCK | More | | Testosterone-cypionate | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | | Testosterone-cypionate | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Testosterone-cypionate | hsa00562 | Inositol phosphate metabolism | 3.69E-02 | 3 | P27987, P19174, P42338 | ITPKB, PLCG1, PIK3CB | More | | Testosterone-cypionate | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Testosterone-cypionate | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Testosterone-cypionate | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Testosterone-cypionate | hsa00730 | Thiamine metabolism | 1.53E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Testosterone-cypionate | hsa00830 | Retinol metabolism | 1.08E-02 | 3 | Q9BPW9, O75911, P11712 | DHRS9, DHRS3, CYP2C9 | More | | Testosterone-cypionate | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Testosterone-cypionate | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Testosterone-cypionate | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Testosterone-cypionate | hsa00983 | Drug metabolism - other enzymes | 1.99E-03 | 5 | P04183, P32320, P05164, Q16772, P09211 | TK1, CDA, MPO, GSTA3, GSTP1 | More | | Testosterone-cypionate | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Testosterone-cypionate | hsa01210 | 2-Oxocarboxylic acid metabolism | 6.96E-04 | 1 | P50213 | IDH3A | More | | Testosterone-cypionate | hsa01240 | Biosynthesis of cofactors | 2.05E-02 | 2 | P36551, O60701 | CPOX, UGDH | More | | Testosterone-cypionate | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Testosterone-cypionate | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Testosterone-cypionate | hsa03008 | Ribosome biogenesis in eukaryotes | 1.46E-02 | 4 | Q9NYH9, P78345, Q9BVP2, Q9GZY0 | UTP6, RPP38, GNL3, NXF2; NXF2B | More | | Testosterone-cypionate | hsa03010 | Ribosome | 1.22E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | | Testosterone-cypionate | hsa03013 | RNA transport | 3.26E-07 | 21 | O14980, P52298, Q09161, O14893, P61326, P38919, Q9GZY0, P37198, Q7Z3B4, P35658, P47813, Q14152, P55884, O75822, P78345, Q14240, Q9BZI7, Q9Y6A5, Q06787, P51114, Q53GS7 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, EIF4A3, NXF2; NXF2B, NUP62, NUP54, NUP214, EIF1AX, EIF3A, EIF3B, EIF3J, RPP38, EIF4A2, UPF3B, TACC3, FMR1, FXR1, GLE1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | O14980 | XPO1 | Exportin-1 | 0.881 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.915 | P22748 | CA4 | Carbonic anhydrase 4 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | -0.879 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.859 | P22748 | CA4 | Carbonic anhydrase 4 | O14893 | GEMIN2 | Gem-associated protein 2 | -0.709 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.776 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P61326 | MAGOH | Protein mago nashi homolog | 0.764 | P22748 | CA4 | Carbonic anhydrase 4 | P61326 | MAGOH | Protein mago nashi homolog | -0.822 | P49768 | PSEN1 | Presenilin-1 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | 0.808 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9GZY0 | NXF2; NXF2B | Nuclear RNA export factor 2 | 0.746 | P49768 | PSEN1 | Presenilin-1 | P37198 | NUP62 | Nuclear pore glycoprotein p62 | -0.716 | P22748 | CA4 | Carbonic anhydrase 4 | Q7Z3B4 | NUP54 | Nucleoporin p54 | -0.776 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.855 | P49768 | PSEN1 | Presenilin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.768 | P22748 | CA4 | Carbonic anhydrase 4 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | 0.827 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.768 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.702 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.707 | P22748 | CA4 | Carbonic anhydrase 4 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | -0.786 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.913 | P49768 | PSEN1 | Presenilin-1 | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.71 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.788 | P22748 | CA4 | Carbonic anhydrase 4 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | -0.869 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.827 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.869 | P22748 | CA4 | Carbonic anhydrase 4 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | -0.731 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.881 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.722 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.815 | P22748 | CA4 | Carbonic anhydrase 4 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | 0.912 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.817 | Q9Y5K5 | UCHL5 | Ubiquitin carboxyl-terminal hydrolase isozyme L5 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.908 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q53GS7 | GLE1 | mRNA export factor GLE1 | -0.723 |
| Testosterone-cypionate | hsa03015 | mRNA surveillance pathway | 9.78E-03 | 6 | O43148, Q16537, P61326, Q9GZY0, P52298, Q53GS7 | RNMT, PPP2R5E, MAGOH, NXF2; NXF2B, NCBP2, GLE1 | More | | Testosterone-cypionate | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Testosterone-cypionate | hsa04012 | ErbB signaling pathway | 3.69E-02 | 3 | Q13191, P19174, P42338 | CBLB, PLCG1, PIK3CB | More | | Testosterone-cypionate | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Testosterone-cypionate | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Testosterone-cypionate | hsa04060 | Cytokine-cytokine receptor interaction | 2.90E-03 | 11 | P14784, P14778, P37173, Q06643, Q13651, Q9HBE5, P78552, P09341, P19875, P80075, Q93038 | IL2RB, IL1R1, TGFBR2, LTB, IL10RA, IL21R, IL13RA1, CXCL1, CXCL2, CCL8, TNFRSF25 | More | | Testosterone-cypionate | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Testosterone-cypionate | hsa04064 | NF-kappa B signaling pathway | 1.11E-04 | 11 | Q13489, Q13546, P14778, P19174, Q04759, Q9UDY8, P06239, P09341, P19875, Q06643, Q9UNE0 | BIRC3, RIPK1, IL1R1, PLCG1, PRKCQ, MALT1, LCK, CXCL1, CXCL2, LTB, EDAR | More | | Testosterone-cypionate | hsa04070 | Phosphatidylinositol signaling system | 1.53E-02 | 2 | Q86XP1, Q96DU7 | DGKH, ITPKC | More | | Testosterone-cypionate | hsa04071 | Sphingolipid signaling pathway | 1.54E-03 | 9 | P17252, Q9H228, P01375, Q13362, Q16537, Q9BX95, Q16539, P04637, P10415 | PRKCA, EDG8, TNF, PPP2R5C, PPP2R5E, SGPP1, MAPK14, TP53, BCL2 | More | | Testosterone-cypionate | hsa04114 | Oocyte meiosis | 1.33E-02 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Testosterone-cypionate | hsa04140 | Autophagy - animal | 1.56E-02 | 4 | Q9Y4H2, P42338, Q9NQL2, Q04759 | IRS2, PIK3CB, RRAGD, PRKCQ | More | | Testosterone-cypionate | hsa04141 | Protein processing in endoplasmic reticulum | 2.78E-02 | 3 | P07384, O95487, O95816 | CAPN1, SEC24B, BAG2 | More | | Testosterone-cypionate | hsa04145 | Phagosome | 6.70E-05 | 12 | P60709, P63261, Q15075, Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | ACTB, ACTG1, EEA1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Testosterone-cypionate | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Testosterone-cypionate | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Testosterone-cypionate | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Testosterone-cypionate | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Testosterone-cypionate | hsa04213 | Longevity regulating pathway - multiple species | 1.56E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Testosterone-cypionate | hsa04217 | Necroptosis | 2.93E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Testosterone-cypionate | hsa04330 | Notch signaling pathway | 2.77E-02 | 2 | Q92542, P49768 | NCSTN, PSEN1 | More | | Testosterone-cypionate | hsa04360 | Axon guidance | 2.74E-03 | 8 | P16333, P20827, O95631, P42338, P07332, P23528, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1, PTPN11 | More | | Testosterone-cypionate | hsa04370 | VEGF signaling pathway | 3.46E-04 | 5 | P19174, P16298, P42338, Q05397, Q02750 | PLCG1, PPP3CB, PIK3CB, PTK2, MAP2K1 | More | | Testosterone-cypionate | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Testosterone-cypionate | hsa04390 | Hippo signaling pathway | 4.35E-02 | 2 | P63261, O15105 | ACTG1, SMAD7 | More | | Testosterone-cypionate | hsa04530 | Tight junction | 2.17E-03 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | | Testosterone-cypionate | hsa04540 | Gap junction | 3.53E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Testosterone-cypionate | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Testosterone-cypionate | hsa04612 | Antigen processing and presentation | 1.97E-02 | 5 | Q07444, Q13241, P01732, P30101, P11142 | KLRC3, KLRD1, CD8A, PDIA3, HSPA8 | More | | Testosterone-cypionate | hsa04613 | Neutrophil extracellular trap formation | 7.19E-04 | 16 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, P63261, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, ACTG1, AQP9, MAPK14 | More | | Testosterone-cypionate | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Testosterone-cypionate | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | | Testosterone-cypionate | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Testosterone-cypionate | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Testosterone-cypionate | hsa04640 | Hematopoietic cell lineage | 1.38E-02 | 6 | P14778, P11215, P25063, P07766, P01732, P09564 | IL1R1, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Testosterone-cypionate | hsa04650 | Natural killer cell mediated cytotoxicity | 3.32E-06 | 12 | P16298, P50591, P19174, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O14931, Q07444 | PPP3CB, TNFSF10, PLCG1, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, KLRC3 | More | | Testosterone-cypionate | hsa04657 | IL-17 signaling pathway | 4.98E-02 | 6 | O00463, Q16539, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF | More | | Testosterone-cypionate | hsa04658 | Th1 and Th2 cell differentiation | 3.01E-05 | 8 | Q04759, P07766, P20963, P19174, P06239, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, TBX21, IL2RB, RUNX3 | More | | Testosterone-cypionate | hsa04659 | Th17 cell differentiation | 4.99E-06 | 12 | Q04759, P19174, P06239, P14784, P14778, Q9HBE5, Q9UL17, P84022, Q13485, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, IL21R, TBX21, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Testosterone-cypionate | hsa04660 | T cell receptor signaling pathway | 5.50E-04 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | | Testosterone-cypionate | hsa04662 | B cell receptor signaling pathway | 1.00E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Testosterone-cypionate | hsa04664 | Fc epsilon RI signaling pathway | 2.47E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Testosterone-cypionate | hsa04666 | Fc gamma R-mediated phagocytosis | 9.96E-03 | 5 | P23528, P49006, P06396, P14598, P17252 | CFL1, MARCKSL1, GSN, NCF1, PRKCA | More | | Testosterone-cypionate | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Testosterone-cypionate | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | | Testosterone-cypionate | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Testosterone-cypionate | hsa04750 | Inflammatory mediator regulation of TRP channels | 2.19E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Testosterone-cypionate | hsa04914 | Progesterone-mediated oocyte maturation | 2.94E-02 | 3 | Q17RY0, P51812, Q02750 | CPEB4, RPS6KA3, MAP2K1 | More | | Testosterone-cypionate | hsa04920 | Adipocytokine signaling pathway | 2.62E-03 | 3 | Q06124, Q9Y478, Q96RR4 | PTPN11, PRKAB1, CAMKK2 | More | | Testosterone-cypionate | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Testosterone-cypionate | hsa04950 | Maturity onset diabetes of the young | 4.70E-02 | 1 | P35557 | GCK | More | | Testosterone-cypionate | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Testosterone-cypionate | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Testosterone-cypionate | hsa04972 | Pancreatic secretion | 1.99E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Testosterone-cypionate | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Testosterone-cypionate | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | | Testosterone-cypionate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.70E-03 | 6 | Q16539, P09341, P19875, P19174, P25024, P25025 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Testosterone-cypionate | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | | Testosterone-cypionate | hsa05132 | Salmonella infection | 1.43E-03 | 11 | Q9UJU2, P63261, Q13546, Q13489, P10415, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371 | LEF1, ACTG1, RIPK1, BIRC3, BCL2, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C | More | | Testosterone-cypionate | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Testosterone-cypionate | hsa05134 | Legionellosis | 4.88E-03 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Testosterone-cypionate | hsa05135 | Yersinia infection | 4.39E-02 | 4 | P06239, P19174, P42338, P01732 | LCK, PLCG1, PIK3CB, CD8A | More | | Testosterone-cypionate | hsa05140 | Leishmaniasis | 5.04E-03 | 8 | P14598, P42224, P13765, O60603, P25963, P29350, P49006, Q15080 | NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, PTPN6, MARCKSL1, NCF4 | More | | Testosterone-cypionate | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Testosterone-cypionate | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Testosterone-cypionate | hsa05146 | Amoebiasis | 3.01E-05 | 8 | P09341, P19875, P14778, P42338, P11215, P05089, P12814, P08311 | CXCL1, CXCL2, IL1R1, PIK3CB, ITGAM, ARG1, ACTN1, CTSG | More | | Testosterone-cypionate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.94E-02 | 4 | P62879, P16298, Q02750, P0CG47 | GNB2, PPP3CB, MAP2K1, UBB | More | | Testosterone-cypionate | hsa05170 | Human immunodeficiency virus 1 infection | 6.02E-03 | 5 | Q02750, P62879, P16298, Q05397, P20333 | MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1B | More | | Testosterone-cypionate | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Testosterone-cypionate | hsa05202 | Transcriptional misregulation in cancer | 3.56E-04 | 16 | Q12778, Q15532, P41732, P14780, P27930, P14923, Q16548, Q13489, Q13077, O15550, P04637, P35226, P05164, P08246, Q9C0K0, P24522 | FOXO1, SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, BIRC3, TRAF1, UTX, TP53, BMI1, MPO, ELA2, BCL11B, GADD45A | More | | Testosterone-cypionate | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | Testosterone-cypionate | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Testosterone-cypionate | hsa05205 | Proteoglycans in cancer | 2.66E-02 | 8 | Q14643, P63261, P04637, P14780, P17252, O60603, Q13635, P08962 | ITPR1, ACTG1, TP53, MMP9, PRKCA, TLR2, PTCH1, CD63 | More | | Testosterone-cypionate | hsa05210 | Colorectal cancer | 3.43E-02 | 2 | Q9UKG1, P37173 | APPL1, TGFBR2 | More | | Testosterone-cypionate | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Testosterone-cypionate | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Testosterone-cypionate | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Testosterone-cypionate | hsa05216 | Thyroid cancer | 3.59E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Testosterone-cypionate | hsa05217 | Basal cell carcinoma | 1.46E-02 | 4 | Q13635, Q9UJU2, P04637, P24522 | PTCH1, LEF1, TP53, GADD45A | More | | Testosterone-cypionate | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Testosterone-cypionate | hsa05221 | Acute myeloid leukemia | 4.95E-02 | 3 | P42338, Q15744, P11215 | PIK3CB, CEBPE, ITGAM | More | | Testosterone-cypionate | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | | Testosterone-cypionate | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Testosterone-cypionate | hsa05231 | Choline metabolism in cancer | 3.99E-02 | 4 | P19174, P23743, O14494, P17252 | PLCG1, DGKA, PLPP1, PRKCA | More | | Testosterone-cypionate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.09E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Testosterone-cypionate | hsa05323 | Rheumatoid arthritis | 4.24E-03 | 6 | Q06643, P13765, P10747, P09341, P19875, O60603 | LTB, HLA-DOB, CD28, CXCL1, CXCL2, TLR2 | More | | Testosterone-cypionate | hsa05340 | Primary immunodeficiency | 4.95E-02 | 3 | P01732, P07766, P06239 | CD8A, CD3E, LCK | More | | Testosterone-cypionate | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Testosterone-cypionate | hsa05415 | Diabetic cardiomyopathy | 8.09E-03 | 8 | P17252, P30405, P14598, Q15080, Q16718, O14521, P37173, P04406 | PRKCA, PPIF, NCF1, NCF4, NDUFA5, SDHD, TGFBR2, GAPDH | More | | Testosterone-cypionate | hsa05418 | Fluid shear stress and atherosclerosis | 4.26E-02 | 6 | P14598, P14780, P63261, P04637, P10415, Q92974 | NCF1, MMP9, ACTG1, TP53, BCL2, ARHGEF2 | More | | |